We report a patient who developed a serum sickness-like illness characterized by fever, arthritis, haematuria and a purpuric eruption 7 days following streptokinase therapy for myocardial infarction. Blood tests demonstrated increased circulating immune complexes. The skin involvement resulted in extensive, painful cutaneous infarction with secondary bacterial infection. Serum sickness is an uncommon but recognized complication of streptokinase therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2230.1995.tb01379.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!